Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 9/20 | 0.45 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | TK2 | O00142 | 1/20 | 0.36 |
| ▸ | PARP1 | P09874 | 1/20 | 0.36 |
| ▸ | SLC6A1 | P30531 | 1/20 | 0.36 |
| ▸ | TK1 | P04183 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3948846 | 0.78 | KIF11 (0.41) | KIF11HRH4CYP2C9TK2TK1 | |
| SCHEMBL8870562 | 0.77 | KIF11 (0.53) | KIF11HRH4TK2SLC6A1TK1 | |
| SCHEMBL8869561 | 0.72 | KIF11 (0.52) | KIF11HRH4CYP3A4CYP2C9KCNH2 | |
| SCHEMBL4151974 | 0.72 | HDAC6 (0.56) | CYP3A4KCNH2 | |
| SCHEMBL31697431 | 0.71 | ALDH1A1 (0.50) | KIF11CYP3A4 | |
| SCHEMBL1884344 | 0.71 | KIF11 (0.50) | KIF11CYP3A4CYP2C9KCNH2TK2 | |
| SCHEMBL8870247 | 0.71 | KIF11 (0.50) | KIF11CYP3A4CYP2C9KCNH2TK2 | |
| SCHEMBL8447265 | 0.71 | KIF11 (0.50) | KIF11CYP3A4CYP2C9KCNH2TK2 | |
| SCHEMBL1884316 | 0.71 | KIF11 (0.50) | KIF11CYP3A4CYP2C9KCNH2TK2 | |
| SCHEMBL1880174 | 0.71 | KIF11 (0.50) | KIF11CYP3A4CYP2C9KCNH2TK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1833977-B1 | ENANTIOCONVERGENT CHEMOENZYMATIC SYNTHESIS OF (R)- GAMMA-AMINO-BETA-HYDROXYBUTYRIC ACID ((R) - GABOB) | COUNCIL SCIENT IND RES (IN) | 2009-04-29 | — | — | EP | disclosed |
| US-7390825-B1 | Process for the preparation of oxazolidinones and method of use thereof | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2008-06-24 | — | — | US | disclosed |
| US-20080146458-A1 | PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2008-06-19 | — | — | US | disclosed |
| US-7374926-B2 | Enantioconvergent chemoenzymatic synthesis of (R)-γ-amino-β-hydroxybutyric acid ((R)-GABOB) | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2008-05-20 | — | — | US | disclosed |
| US-20070265451-A1 | Process for the preparation of oxazolidinones and method of use thereof | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2007-11-15 | — | — | US | disclosed |
| EP-1833977-A1 | ENANTIOCONVERGENT CHEMOENZYMATIC SYNTHESIS OF (R)- GAMMA-AMINO-BETA-HYDROXYBUTYRIC ACID ((R) -GABOB) | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2007-09-19 | — | — | EP | disclosed |
| EP-1578723-A4 | PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF | UNIV MICHIGAN STATE (US) | 2006-11-02 | — | — | EP | disclosed |
| US-20060141606-A1 | Enantioconvergent chemoenzymatic synthesis of (R)-gamma-amino-beta-hydroxybutyric acid ((R)-GABOB) | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2006-06-29 | — | — | US | disclosed |
| WO-2006064513-A1 | ENANTIOCONVERGENT CHEMOENZYMATIC SYNTHESIS OF (R)- GAMMA-AMINO-BETA-HYDROXYBUTYRIC ACID ((R) -GABOB) | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2006-06-22 | — | — | WO | disclosed |
| EP-1324989-B1 | 5-TRITYLOXYMETHYL-2-OXAZOLIDINONE AND PROCESS FOR THE PREPARATION THEREOF | UNIV MICHIGAN STATE (US) | 2006-06-14 | — | — | EP | disclosed |
| EP-1578723-A3 | PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF | MICHIGAN STATE UNIVERSITY (US) | 2005-10-20 | — | — | EP | disclosed |
| EP-1578723-A2 | PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF | MICHIGAN STATE UNIVERSITY (US) | 2005-09-28 | — | — | EP | disclosed |
| EP-1324989-A4 | 5-TRITYLOXYMETHYL-OXAZOLIDINONES AND PROCESS FOR THE PREPARATION THEREOF | UNIV MICHIGAN STATE (US) | 2005-07-20 | — | — | EP | disclosed |
| WO-2003106413-A2 | PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF | MICHIGAN STATE UNIVERSITY (US) | 2003-12-24 | — | — | WO | disclosed |
| EP-1324989-A1 | 5-TRITYLOXYMETHYL-OXAZOLIDINONES AND PROCESS FOR THE PREPARATION THEREOF | MICHIGAN STATE UNIVERSITY (US) | 2003-07-09 | — | — | EP | disclosed |
| WO-2002024670-A1 | 5-TRITYLOXYMETHYL-OXAZOLIDINONES AND PROCESS FOR THE PREPARATION THEREOF | MICHIGAN STATE UNIVERSITY (US) | 2002-03-28 | — | — | WO | disclosed |
| US-6288239-B1 | STIRRING A TRITYL ETHER OF 3,4-DIHYDROXYBUTYRAMIDE WITH ALKALINE OR ALKALI HYDROXIDE TO PRODUCE 5-TRITYLOXYMETHYL OXAZOLINE AND REMOVAL OF OXAZOLIDINONE DERIVATIVE | BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY | 2001-09-11 | — | — | US | disclosed |
| US-6288239-B1 | STIRRING A TRITYL ETHER OF 3,4-DIHYDROXYBUTYRAMIDE WITH ALKALINE OR ALKALI HYDROXIDE TO PRODUCE 5-TRITYLOXYMETHYL OXAZOLINE AND REMOVAL OF OXAZOLIDINONE DERIVATIVE | BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY | 2001-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070265451-A1 | Process for the preparation of oxazolidinones and method of use thereof | OXA1L, OTC, ODC1 | KIF11 3787/4885HRH4 3459/4885CYP3A4 137/4885 |
| US-20080146458-A1 | PROCESS FOR THE PREPARATION OF OXAZOLIDINONES AND METHOD OF USE THEREOF | OXA1L, OGFOD1, CYP51A1 | KIF11 2957/4885HRH4 2065/4885CYP3A4 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.